The final agenda for the Eighth International Conference on Cell Therapy for Cardiovascular Disease, sponsored by the Cardiovascular Research Foundation, is now available online at http://celltherapy.
This year's conference will focus on pivotal preclinical and clinical studies on the path to commercialization, focusing on the status of molecular, cell, and tissue products, in addition to delivery systems.
Recent advances in stem cell research demonstrate great potential as breakthrough therapies for conditions like diabetes, Parkinson's and heart disease. Now in its 12th year of clinical trials, the application of stem cells in the treatment of cardiovascular diseases has realized many notable successes, as well as identified challenges that await the next round of clinical studies. Renowned thought leaders in this field will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies.
Sessions will focus on:
- Pre-Clinical and Clinical Trial Results
- Clinical Methods: Biologics Delivery
- Chronic Vascular Insufficiency
- Heart Failure and Chronic Myocardial Disease
- Macro and Micro Structure: Implications for Tissue Repair
- Cell Therapy in South and Central America
- Goals and Logistics for the Next Decade
Course Director, Conference on Cell Therapy for Cardiovascular Disease
Warren Sherman, MD
NewYork-Presbyterian Hospital/Columbia University Medical Center New York, NY
Jozef Bartunek, MD, PhD
Cardiovascular Center, OLV Hospital
Henricus J. Duckers, MD, PhD
Erasmus Medical Center
Rotterdam, The Netherlands
Amit Patel, MD, MS
University of Utah
Salt Lake City, UT
Marc S. Penn, MD, PhD
Summa Health System
Gustav Steinhoff, MD, PhD
University of Rostock
Gordana Vunjak-Novakovic, PhD
Columbia University Medical Center
New York, NY
Wojciech Wojakowski, MD, PhD
Third Division of Cardiology
January 23-25, 2013
Vivian and Seymour Milstein Family Heart Center
Myrna L. Daniels Auditorium
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY
For more information visit: http://celltherapy.
HOW TO REGISTER:
Media may apply for registration by emailing email@example.com.
The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine.